Kane Biotech Inc. - Biotechnology Company Focused on Developing Applications and Products for their Biofilm Technology

Kane Biotech (TSX-V: KNE) is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, according to the Company’s website (see here: www.kanebiotech.com).

SNNLive spoke with Mark Ahrens-Townsend, President and CEO of Kane Biotech Inc. at The MicroCap Conference 2017 in New York City, NY, and they discuss the following topics:

- Overview and history of Kane Biotech Inc.

- Biofilm industry

- Clinical Development

- Kane Biotech’s competitive advantage

- Mr. Ahrens-Townsend’s background

- Growth drivers

For more information about Kane Biotech Inc., please visit: www.kanebiotech.com

The interview may contain forward-looking statements about Kane Biotech Inc. See Kane Biotech Inc.'s periodic filings with SEDAR for more complete information.